hotspot -WSS

hotspot

author：Wikipedia 2025-10-01 01:49:59 - browse：17

illustration of a colorful DNA strand, partly broken into pieces. -- health coverage from STAT — Adobe

BALTIMORE — An ambitious effort to cure HIV with CRISPR genome editing fell short in an early clinical trial, investigators announced Friday morning.

In the study, run by Excision BioTherapeutics, researchers tried to use the gene editing tool to address a chief reason HIV has been so hard to cure. While antiviral drugs can clear patients of replicating virus, HIV is able to worm its way into a patients’ own DNA in certain cells. If the patient ever stops taking medicines, those cells start pumping out HIV particles and the infection roars back.

Researchers hoped they could send CRISPR to those cells and, by cutting the HIV DNA lurking there at two spots, slice out the virus. In the Phase 1 trial, investigators administered the treatment to five patients. They then took three of them off conventional antiviral treatment.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Dana Farber says 6 studies to be retracted and 31 corrected

hotspot

WSS

Novo Nordisk touts Wegovy study, but still struggling with supply

Aspartame and sugar

Aspartame and sugar

Pumping milk in bathrooms at health conferences is common

Immunocompromised patients offer clues on chronic Covid

TikTok, Instagram influencers need more rules for drug ads

focus

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

Anesthesiologist group: stop taking Ozempic before surgery

YouTube cracks down on misinformation on cancer treatment

How one medical school became remarkably diverse

What to know about the judge who will handle the Trump case

George Santos makes 1st court appearance after pleading not guilty to 13 counts

The inclusion problem at the heart of rehabilitation research

Supreme Court strikes down use of affirmative action

Maisha Meds is a PBM, but don't call it that

United colonoscopy coverage change 'may cost lives,' doctors say

Head of FDA's diagnostics center, who led through Covid, retires

Wikipedia

Aspartame and sugar

Senators push IRS to launch nonprofit hospital probe

Judge sides with young activists in first

Bird flu researchers hone in on Finland’s mink farms

Health AI: on the border between health care and tech

Montana youths win climate lawsuit against state for promoting fossil fuels

focus

leisure time

hotspot

hotspot